Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 10:45 (2641 d 14:27 ago) – Posting: # 20125
Views: 7,099

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


Edit: Category changed; see also this post #1. Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
318 visitors (0 registered, 318 guests [including 15 identified bots]).
Forum time: 01:13 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5